Clinical Trial Update: A Study of Apatinib for Advanced Hepatocellular Carcinoma Patients After First-line Treatment Failure [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update for Apatinib in advanced hepatocellular carcinoma after first-line treatment failure, covering phase 1 and phase 2 cohorts with the curren…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• Apatinib (apatinib)

Snippet

Sponsor: The First Affiliated Hospital of Zhengzhou University | Conditions: Hepatocellular Carcinoma | Phase 1, Phase 2 | Status: UNKNOWN